 | MOLECULAR MECHANISMS OF FEVER
Copyright © 1998 by the New York Academy of Sciences
description
Annals of the New York Academy of Sciences 856:76-82 (1998)
© 1998 New York Academy of Sciences
Prostaglandin E2 in the Pathogenesis of Fever: An Updatea
FLAVIO COCEANIb AND
EYUP S. AKARSUc
Division of Neurosciences, Research Institute, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8
aThis work was supported by the Medical Research Council of Canada. E.S.A. was supported in part by a NATO Science Fellowship awarded through the Scientific Research Council of Turkey (TUBITAK).
bAddress for correspondence: Dr. Flavio Coceani, Division of Neurosciences, Hospital for Sick Children, 555 University Ave., Toronto, Ontario, Canada M5G 1X8. Phone, 416/813-5752; fax, 416/813-5086; e-mail, coceani{at}sickkids.on.ca
cPresent address: Department of Pharmacology, Faculty of Medicine, Ankara University, Ankara, Turkey.
Prostaglandin E 2 (PGE 2) is recognized as a key intermediate in the sequence of events leading to fever. Normally undetectable or barely detectable in brain, it rises selectively on exposure to an infectious noxa and the attendant generation of pyrogenic cytokines outside and, in the case of interleukin (IL)-6, inside the brain. The mechanism by which pyrogens in the circulation promote the appearance of PGE 2 within the confines of brain is not clear, and it is not known how PGE 2 activation is selective with IL-6 being induced in brain. We have found that the cerebral microvasculature is not suitable as a source of PGE 2 in response to blood-borne pyrogens. In addition, we show that IL-6 differs from other pyrogens in being able to stimulate specifically PGE 2 synthesis. Nevertheless, brain-derived IL-6 does not appear to be necessary for PGE 2 activation and the attendant fever. We conclude that signal-transducing mechanisms operating across the blood-brain barrier are most critical for the development of the febrile reponse to a systemic noxa.
This article has been cited by other articles:
|
|
|
|
 
A. O. Hofstetter, S. Saha, V. Siljehav, P.-J. Jakobsson, and E. Herlenius
The induced prostaglandin E2 pathway is a key regulator of the respiratory response to infection and hypoxia in neonates
PNAS,
June 5, 2007;
104(23):
9894 - 9899.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Gray, S. K. Maloney, and P. R. Kamerman
Lipopolysaccharide-induced fever in Pekin ducks is mediated by prostaglandins and nitric oxide and modulated by adrenocortical hormones
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2005;
289(5):
R1258 - R1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Aiko, Y. Yoshizumi, S. Tsuwano, M. Shimanouchi, Y. Sugiura, and T. Maehara
The Effects of Immediate Enteral Feeding with a Formula Containing High Levels of {omega}-3 Fatty Acids in Patients After Surgery for Esophageal Cancer
JPEN J Parenter Enteral Nutr,
May 1, 2005;
29(3):
141 - 147.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. V. Tabarean, M. M. Behrens, T. Bartfai, and H. Korn
Prostaglandin E2-increased thermosensitivity of anterior hypothalamic neurons is associated with depressed inhibition
PNAS,
February 24, 2004;
101(8):
2590 - 2595.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. F. MORRISON
Differential Regulation of Sympathetic Outflows to Vasoconstrictor and Thermoregulatory Effectors
Ann. N.Y. Acad. Sci.,
June 1, 2001;
940(1):
286 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Siegle, T. Klein, M.-H. Zou, P. Fritz, and M. Kömhoff
Distribution and Cellular Localization of Prostacyclin Synthase in Human Brain
J. Histochem. Cytochem.,
May 1, 2000;
48(5):
631 - 642.
[Abstract]
[Full Text]
|
|
|
|
